Tower Research Capital LLC (Trc) Relmada Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $4.87 Billion
  • Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 760 shares of RLMD stock, worth $212. This represents 0.0% of its overall portfolio holdings.

Number of Shares
760
Holding current value
$212
% of portfolio
0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$0.35 - $3.65 $266 - $2,774
760 New
760 $0
Q2 2024

Aug 13, 2024
SELL
$2.93 - $4.94 $20,515 - $34,589
-7,002 Reduced 71.77%
2,754 $8,000
Q1 2024

May 15, 2024
BUY
$3.1 - $6.8 $22,651 - $49,687
7,307 Added 298.37%
9,756 $45,000
Q4 2023

Feb 13, 2024
BUY
$2.45 - $4.22 $1,810 - $3,118
739 Added 43.22%
2,449 $10,000
Q3 2023

Nov 14, 2023
SELL
$2.48 - $3.79 $7,705 - $11,775
-3,107 Reduced 64.5%
1,710 $5,000
Q2 2023

Aug 14, 2023
BUY
$2.22 - $3.54 $439 - $700
198 Added 4.29%
4,817 $11,000
Q1 2023

May 09, 2023
SELL
$2.24 - $4.76 $43,505 - $92,448
-19,422 Reduced 80.79%
4,619 $10,000
Q4 2022

Feb 10, 2023
BUY
$2.17 - $35.84 $50,320 - $831,093
23,189 Added 2721.71%
24,041 $84,000
Q3 2022

Nov 10, 2022
SELL
$18.3 - $37.02 $11,291 - $22,841
-617 Reduced 42.0%
852 $32,000
Q2 2022

Aug 15, 2022
BUY
$16.5 - $30.34 $20,806 - $38,258
1,261 Added 606.25%
1,469 $28,000
Q1 2022

May 12, 2022
SELL
$16.72 - $26.99 $17,037 - $27,502
-1,019 Reduced 83.05%
208 $6,000
Q4 2021

Feb 14, 2022
BUY
$16.93 - $26.82 $9,243 - $14,643
546 Added 80.18%
1,227 $28,000
Q3 2021

Nov 15, 2021
SELL
$21.86 - $34.77 $7,869 - $12,517
-360 Reduced 34.58%
681 $18,000
Q2 2021

Aug 16, 2021
SELL
$29.55 - $39.15 $22,369 - $29,636
-757 Reduced 42.1%
1,041 $33,000
Q1 2021

May 17, 2021
BUY
$31.52 - $39.28 $19,542 - $24,353
620 Added 52.63%
1,798 $63,000
Q4 2020

Feb 16, 2021
SELL
$29.88 - $39.8 $331,787 - $441,939
-11,104 Reduced 90.41%
1,178 $37,000
Q3 2020

Nov 16, 2020
BUY
$34.42 - $43.78 $391,734 - $498,260
11,381 Added 1263.15%
12,282 $462,000
Q2 2020

Aug 13, 2020
BUY
$31.59 - $49.98 $28,462 - $45,031
901 New
901 $40,000
Q1 2020

May 15, 2020
SELL
$23.78 - $50.12 $50,960 - $107,407
-2,143 Closed
0 $0
Q4 2019

Feb 07, 2020
BUY
$10.1 - $47.18 $21,644 - $101,106
2,143 New
2,143 $84,000

Others Institutions Holding RLMD

# of Institutions
54
Shares Held
8.29M
Call Options Held
364K
Put Options Held
46.5K
View Full List

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $8.01M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email